Cargando…

A survey of healthcare workers’ recommendations about human papillomavirus vaccination

PURPOSE: The human papillomavirus (HPV) vaccine is safe and effective for preventing HPV-related diseases. However, HPV vaccination rates in Japan are low because the “Ministry of Health, Labour and Welfare” had stopped recommending vaccination. We assessed healthcare workers’ (HCWs) current recomme...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishioka, Hitomi, Onishi, Tomoko, Kitano, Taito, Takeyama, Masahiro, Imakita, Natsuko, Kasahara, Kei, Kawaguchi, Ryuji, Masaki, Jennifer Akiko, Nogami, Keiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200650/
https://www.ncbi.nlm.nih.gov/pubmed/35799873
http://dx.doi.org/10.7774/cevr.2022.11.2.149
_version_ 1784728110046904320
author Nishioka, Hitomi
Onishi, Tomoko
Kitano, Taito
Takeyama, Masahiro
Imakita, Natsuko
Kasahara, Kei
Kawaguchi, Ryuji
Masaki, Jennifer Akiko
Nogami, Keiji
author_facet Nishioka, Hitomi
Onishi, Tomoko
Kitano, Taito
Takeyama, Masahiro
Imakita, Natsuko
Kasahara, Kei
Kawaguchi, Ryuji
Masaki, Jennifer Akiko
Nogami, Keiji
author_sort Nishioka, Hitomi
collection PubMed
description PURPOSE: The human papillomavirus (HPV) vaccine is safe and effective for preventing HPV-related diseases. However, HPV vaccination rates in Japan are low because the “Ministry of Health, Labour and Welfare” had stopped recommending vaccination. We assessed healthcare workers’ (HCWs) current recommendations regarding the HPV vaccine and how the provision of information about HPV vaccination affected their recommendations. MATERIALS AND METHODS: A survey was conducted among nurses and physicians in Nara prefecture from March 2021 to July 2021. The questionnaire asked about their understanding, recommendations, and opinions regarding HPV vaccination. Before answering the last two questions (optional), the HCWs read evidence-based information quantifying the risks and benefits of HPV vaccination. RESULTS: A total of 441 HCWs completed the questionnaire. Only 19% of HCWs always recommended HPV vaccination for girls aged 12–16 years. The evidence-based information significantly improved the percentage of HCWs who would “always recommend” vaccination. CONCLUSION: This study showed that the proportion of HCWs who recommend HPV vaccination to adolescent girls remains low in Japan. However, we found that evidence-based information describing the causal relationship between adverse events and vaccination, quantifying the risks and benefits, noting the importance of HCW communications with families, and reporting the recommendations of national societies, might increase HCWs’ recommendations for HPV vaccination.
format Online
Article
Text
id pubmed-9200650
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Vaccine Society
record_format MEDLINE/PubMed
spelling pubmed-92006502022-07-06 A survey of healthcare workers’ recommendations about human papillomavirus vaccination Nishioka, Hitomi Onishi, Tomoko Kitano, Taito Takeyama, Masahiro Imakita, Natsuko Kasahara, Kei Kawaguchi, Ryuji Masaki, Jennifer Akiko Nogami, Keiji Clin Exp Vaccine Res Original Article PURPOSE: The human papillomavirus (HPV) vaccine is safe and effective for preventing HPV-related diseases. However, HPV vaccination rates in Japan are low because the “Ministry of Health, Labour and Welfare” had stopped recommending vaccination. We assessed healthcare workers’ (HCWs) current recommendations regarding the HPV vaccine and how the provision of information about HPV vaccination affected their recommendations. MATERIALS AND METHODS: A survey was conducted among nurses and physicians in Nara prefecture from March 2021 to July 2021. The questionnaire asked about their understanding, recommendations, and opinions regarding HPV vaccination. Before answering the last two questions (optional), the HCWs read evidence-based information quantifying the risks and benefits of HPV vaccination. RESULTS: A total of 441 HCWs completed the questionnaire. Only 19% of HCWs always recommended HPV vaccination for girls aged 12–16 years. The evidence-based information significantly improved the percentage of HCWs who would “always recommend” vaccination. CONCLUSION: This study showed that the proportion of HCWs who recommend HPV vaccination to adolescent girls remains low in Japan. However, we found that evidence-based information describing the causal relationship between adverse events and vaccination, quantifying the risks and benefits, noting the importance of HCW communications with families, and reporting the recommendations of national societies, might increase HCWs’ recommendations for HPV vaccination. The Korean Vaccine Society 2022-05 2022-05-31 /pmc/articles/PMC9200650/ /pubmed/35799873 http://dx.doi.org/10.7774/cevr.2022.11.2.149 Text en © Korean Vaccine Society. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Nishioka, Hitomi
Onishi, Tomoko
Kitano, Taito
Takeyama, Masahiro
Imakita, Natsuko
Kasahara, Kei
Kawaguchi, Ryuji
Masaki, Jennifer Akiko
Nogami, Keiji
A survey of healthcare workers’ recommendations about human papillomavirus vaccination
title A survey of healthcare workers’ recommendations about human papillomavirus vaccination
title_full A survey of healthcare workers’ recommendations about human papillomavirus vaccination
title_fullStr A survey of healthcare workers’ recommendations about human papillomavirus vaccination
title_full_unstemmed A survey of healthcare workers’ recommendations about human papillomavirus vaccination
title_short A survey of healthcare workers’ recommendations about human papillomavirus vaccination
title_sort survey of healthcare workers’ recommendations about human papillomavirus vaccination
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200650/
https://www.ncbi.nlm.nih.gov/pubmed/35799873
http://dx.doi.org/10.7774/cevr.2022.11.2.149
work_keys_str_mv AT nishiokahitomi asurveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT onishitomoko asurveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT kitanotaito asurveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT takeyamamasahiro asurveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT imakitanatsuko asurveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT kasaharakei asurveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT kawaguchiryuji asurveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT masakijenniferakiko asurveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT nogamikeiji asurveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT nishiokahitomi surveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT onishitomoko surveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT kitanotaito surveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT takeyamamasahiro surveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT imakitanatsuko surveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT kasaharakei surveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT kawaguchiryuji surveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT masakijenniferakiko surveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination
AT nogamikeiji surveyofhealthcareworkersrecommendationsabouthumanpapillomavirusvaccination